Elastrin Therapeutics
PrivateLast Round
Debt
Sep 12, 2024
Total Funding Raised
$17.58M
Company Overview
Elastrin Therapeutics operates in Healthcare & Life Sciences and is based in Greenville, South Carolina. Its latest recorded funding round was a Debt round in September 2024.
Elastrin Therapeutics is a biotechnology company that develops nanoparticle-based therapies to reverse cardiovascular calcification and restore tissue elasticity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elastrin Therapeutics Comparables
Compare Elastrin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revel Pharmaceuticals | 76% | |
| NanoPhoria Bioscience | 75% | |
| Cyclarity Therapeutics | 74% |
For institutional investors. Book with your work email.
Elastrin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 12, 2024 | ||||
| Series A | Nov 3, 2023 | ||||
| Convertible Debt | Sep 8, 2023 | ||||
| Seed | Apr 7, 2022 | ||||
| Pre Seed | Mar 1, 2021 |
For institutional investors. Book with your work email.
Elastrin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| Starbloom Capital | Seed |
| SC Launch | Seed |
| SCRA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2024
$500K debt round completed.
- Nov 3, 2023
Raised $4.75M in Series A funding.
For institutional investors. Book with your work email.
Elastrin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elastrin Therapeutics's valuation, stock price, and market status.
Is Elastrin Therapeutics a public or private company?
Elastrin Therapeutics is a private company.
What is the current stock price of Elastrin Therapeutics?
Elastrin Therapeutics is a private company, so its shares have no public market price. Caplight tracks Elastrin Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elastrin Therapeutics worth (valuation)?
Valuation information for Elastrin Therapeutics is not publicly available.
Can I buy Elastrin Therapeutics stock?
Elastrin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elastrin Therapeutics's last funding round?
Elastrin Therapeutics's most recent funding round was Debt on September 12, 2024.
Who are the main investors in Elastrin Therapeutics?
Key investors in Elastrin Therapeutics include Kizoo Technology Capital.
Will Elastrin Therapeutics IPO soon?
No public IPO plans have been announced for Elastrin Therapeutics.
How can I track Elastrin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Elastrin Therapeutics's shares on secondary markets.